A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2011
12/20/2011	US8080253 Chimeric VEGF peptides
12/20/2011	US8080252 Compounds and methods of modulating angiogenesis
12/20/2011	US8080251 Antigenic peptides
12/20/2011	US8080250 Immunoconjugates with an intracellularly-cleavable linkage
12/20/2011	US8080249 Methods to treating chronic obstructive pulmonary disease
12/20/2011	US8080248 Method of treating rheumatoid arthritis with an IL-6R antibody
12/20/2011	US8080247 Anti-IL-12 antibodies
12/20/2011	US8080245 Anti-pathogen immunoadhesins
12/20/2011	US8080244 Anti-influenza M2e antibody
12/20/2011	US8080243 Isolated antibody which specifically binds to PCSK9
12/20/2011	US8080242 Anti-HPA
12/20/2011	US8080241 Viruses for the treatment of cellular proliferative disorders
12/20/2011	US8080240 Parvovirus methods and compositions for killing neoplastic cells
12/20/2011	CA2598510C Q3 sparc deletion mutant and uses thereof
12/20/2011	CA2447450C Corona-virus-like particles comprising functionally deleted genomes
12/20/2011	CA2386858C 36p6d5: secreted tumor antigen
12/20/2011	CA2362454C Viral vectors and viral vaccines based on recombinant porcine adenoviruses
12/20/2011	CA2329754C Peptide composition as immunogen for the treatment of allergy
12/20/2011	CA2321161C Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2011	CA2252375C Nucleic acid vaccination for parvoviral infections
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	WO2011156774A2 Multivalent glycopeptide constructs and uses thereof
12/15/2011	WO2011156694A2 Enrichment and purification of infectious prion proteins
12/15/2011	WO2011156594A2 Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
12/15/2011	WO2011156324A1 Cgrp antibodies
12/15/2011	WO2011156242A2 Improved anti-lysophospholipid antibody design using antibody structures
12/15/2011	WO2011155998A2 Oral vaccination of fish with live attenuated edwardsiella ictaluri vaccines
12/15/2011	WO2011155822A1 Trisaccharide derivates, and their use as adjuvants
12/15/2011	WO2011155705A2 Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol
12/15/2011	WO2011155607A1 Anti-tim-3 antibody
12/15/2011	WO2011155579A1 ANTI-Trop-2 ANTIBODY
12/15/2011	WO2011154976A2 Improved influenza vaccine
12/15/2011	WO2011154878A1 Ige ch3 peptide vaccine
12/15/2011	WO2011154863A1 Her-2 peptides and vaccines
12/15/2011	WO2011154476A1 Anti-tumor composition
12/15/2011	WO2011154444A1 Novel process
12/15/2011	WO2011154443A1 Novel process
12/15/2011	WO2011154420A2 Tear lipocalin muteins binding il-4 r alpha
12/15/2011	WO2011154119A1 Preparation of a stabilized dry oral vaccine composed of a live attenuated virus
12/15/2011	WO2011153959A1 Conjugates of flu virus m2 or ha2 fragments and protein carriers, and pharmaceutical use thereof
12/15/2011	WO2011153592A1 Therapeutic molecules
12/15/2011	WO2011153590A1 Use of interferon epsilon in methods of diagnosis and treatment
12/15/2011	WO2011137322A3 Methods and compositions for treating celiac disease
12/15/2011	WO2011133894A3 Protein drug formulations and packages
12/15/2011	WO2011133521A3 Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor
12/15/2011	WO2011131208A4 Bivalent enterotoxemia vaccine for veterinary use
12/15/2011	WO2011130878A9 Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
12/15/2011	WO2011123427A9 Treatment of cancer by inhibiting activity or expression of late sv-40 factor
12/15/2011	WO2011106300A3 Anti-angiogenesis therapy for the treatment of ovarian cancer
12/15/2011	WO2011098778A3 Peptides for vaccines against birch allergy
12/15/2011	WO2011098424A3 Treatment of a metabolic disorder
12/15/2011	WO2011097384A3 Tumor targeted delivery of immunomodulators by nanoplymers
12/15/2011	WO2011091401A9 Treatment of immune disorders using kainate receptor antagonists
12/15/2011	WO2011091376A3 Immunogenic influenza composition
12/15/2011	WO2011091027A3 Recombinant live attenuated foot-and-mouth disease (fmd) vaccine containing mutations in the l protein coding region
12/15/2011	WO2011090708A3 Recombinant ndv antigen and uses thereof
12/15/2011	WO2011080314A3 Novel modulators of trail signalling
12/15/2011	WO2011056060A3 Recombinant matrix protein of nipah virus
12/15/2011	WO2011008770A3 Methods for inhibiting yellow color and peroxide formation in a composition
12/15/2011	US20110307964 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
12/15/2011	US20110306756 Prevention and Treatment of Amyloidogenic Disease
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents
12/15/2011	US20110305765 Preparation and methodology of silk fibroin nanoparticles
12/15/2011	US20110305753 Treatment of celiac disease with IgA
12/15/2011	US20110305751 Glutathione-based drug delivery system
12/15/2011	US20110305749 HIV-1 Envelope Polypeptides for HIV Vaccine
12/15/2011	US20110305748 Vaccines for Pandemic Influenza
12/15/2011	US20110305735 Skin antiaging treatment
12/15/2011	US20110305730 Mono-and disaccharide derivatives
12/15/2011	US20110305728 Drug for treating infections
12/15/2011	US20110305727 Rsv f protein compositions and methods for making same
12/15/2011	US20110305726 Infectious Bronchitis Vaccines Derived From IB-qx-like Vaccine Strains
12/15/2011	US20110305725 Methods and compositions for immunizing pigs against porcine circovirus
12/15/2011	US20110305724 Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
12/15/2011	US20110305723 Molecular Antigen Array
12/15/2011	US20110305722 Mage-c2 antigenic peptides and uses thereof
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305720 Peptide adjuvants
12/15/2011	US20110305719 Inhibition of Pro-Inflammatory Cytokine Induced Response
12/15/2011	US20110305718 Recombinant Protein Body-Inducing Polypeptides
12/15/2011	US20110305717 Cultured myeloid dendritic cells isolated from peyer's patches and uses thereof
12/15/2011	US20110305716 Targeted cytokine for treatment of diseases
12/15/2011	US20110305715 Antibodies to 3-hydroxycotinine and methods of use thereof
12/15/2011	US20110305714 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
12/15/2011	US20110305713 Methods and compositions to enhance vaccine efficacy by reprogramming regulatory t cells
12/15/2011	US20110305712 Ctla4 proteins and their uses
12/15/2011	US20110305711 Cgrp antibodies
12/15/2011	US20110305710 Novel compounds for the treatment of glaucoma or ocular hypertension
12/15/2011	US20110305709 Calcium sensor stim1 and the platelet soc channel orai1 (cracm1) are essential for pathological thrombus formation
12/15/2011	US20110305708 Compositions and methods for the therapy and diagnosis of cytomegalovirus
12/15/2011	US20110305707 Compositions and methods for treating cancer
12/15/2011	US20110305706 Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305704 Antibody to cytolethal distending toxin of campylobacter jejuni
12/15/2011	US20110305703 Isolated vegf-c and vegf-d peptides and uses thereof
12/15/2011	US20110305702 Epitopes
12/15/2011	US20110305701 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
12/15/2011	US20110305700 Anti-lipid antibodies
12/15/2011	US20110305699 Treating Oral Cancer with Anti-IL-20 Antibody

1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 1823